Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.
Clinical trial NCT01756456 · COMPLETED
Trial details
- NCT number
- NCT01756456
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-04-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.